340 related articles for article (PubMed ID: 18336598)
1. Microsatellite analysis of allelic imbalance in tumour and blood from patients with prostate cancer.
Schwarzenbach H; Chun FK; Müller I; Seidel C; Urban K; Erbersdobler A; Huland H; Pantel K; Friedrich MG
BJU Int; 2008 Jul; 102(2):253-8. PubMed ID: 18336598
[TBL] [Abstract][Full Text] [Related]
2. Comparison of genetic alterations detected in circulating microsatellite DNA in blood plasma samples of patients with prostate cancer and benign prostatic hyperplasia.
Müller I; Urban K; Pantel K; Schwarzenbach H
Ann N Y Acad Sci; 2006 Sep; 1075():222-9. PubMed ID: 17108215
[TBL] [Abstract][Full Text] [Related]
3. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
[TBL] [Abstract][Full Text] [Related]
4. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
[TBL] [Abstract][Full Text] [Related]
5. Multigene methylation analysis for detection and staging of prostate cancer.
Enokida H; Shiina H; Urakami S; Igawa M; Ogishima T; Li LC; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
Clin Cancer Res; 2005 Sep; 11(18):6582-8. PubMed ID: 16166436
[TBL] [Abstract][Full Text] [Related]
6. A comparative microsatellite analysis of colorectal cancer in patients <35 years and >50 years of age.
Naidoo R; Tarin M; Chetty R
Am J Gastroenterol; 2000 Nov; 95(11):3266-75. PubMed ID: 11095352
[TBL] [Abstract][Full Text] [Related]
7. Cell-free tumor DNA in blood plasma as a marker for circulating tumor cells in prostate cancer.
Schwarzenbach H; Alix-Panabières C; Müller I; Letang N; Vendrell JP; Rebillard X; Pantel K
Clin Cancer Res; 2009 Feb; 15(3):1032-8. PubMed ID: 19188176
[TBL] [Abstract][Full Text] [Related]
8. Allelic imbalance and biochemical outcome after radical prostatectomy.
Bott SR; Masters JR; Parkinson MC; Kirby RS; Feneley M; Hooper J; Williamson M
Prostate Cancer Prostatic Dis; 2006; 9(2):160-8. PubMed ID: 16534511
[TBL] [Abstract][Full Text] [Related]
9. Role of cell-free plasma DNA as a diagnostic marker for prostate cancer.
Allen D; Butt A; Cahill D; Wheeler M; Popert R; Swaminathan R
Ann N Y Acad Sci; 2004 Jun; 1022():76-80. PubMed ID: 15251943
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer.
Chun FK; Müller I; Lange I; Friedrich MG; Erbersdobler A; Karakiewicz PI; Graefen M; Pantel K; Huland H; Schwarzenbach H
BJU Int; 2006 Sep; 98(3):544-8. PubMed ID: 16925751
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of allelic imbalance of chromosome arms 7q, 8p, 16q, and 18q in stage T3N0M0 prostate cancer.
Jenkins R; Takahashi S; DeLacey K; Bergstralh E; Lieber M
Genes Chromosomes Cancer; 1998 Feb; 21(2):131-43. PubMed ID: 9491325
[TBL] [Abstract][Full Text] [Related]
12. Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer.
Fromont G; Valeri A; Cher M; Pontes JE; Vallancien G; Validire P; Latil A; Cussenot O
Prostate; 2005 Dec; 65(4):341-6. PubMed ID: 16015610
[TBL] [Abstract][Full Text] [Related]
13. Detection of tumor-specific DNA in blood and bone marrow plasma from patients with prostate cancer.
Schwarzenbach H; Chun FK; Lange I; Carpenter S; Gottberg M; Erbersdobler A; Friedrich MG; Huland H; Pantel K
Int J Cancer; 2007 Apr; 120(7):1465-71. PubMed ID: 17205532
[TBL] [Abstract][Full Text] [Related]
14. Allelic imbalance in hereditary and sporadic prostate cancer.
Verhage BA; van Houwelingen K; Ruijter TE; Kiemeney LA; Schalken JA
Prostate; 2003 Jan; 54(1):50-7. PubMed ID: 12481255
[TBL] [Abstract][Full Text] [Related]
15. Genetic changes in Slovenian patients with gastric adenocarcinoma evaluated in terms of microsatellite DNA.
Gazvoda B; Juvan R; Zupanic-Pajnic I; Repse S; Ferlan-Marolt K; Balazic J; Komel R
Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1082-9. PubMed ID: 17998833
[TBL] [Abstract][Full Text] [Related]
16. [Microsatellite alterations of circulating DNA in the plasma of patients with hepatocellular carcinoma].
Pang JZ; Qin LX; Ren N; Ye QH; Ying WD; Liu YK; Tang ZY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1662-5. PubMed ID: 16854315
[TBL] [Abstract][Full Text] [Related]
17. New evaluation of plasma DNA microsatellite analysis in patients with TCC of the urinary bladder.
Fornari D; Steven K; Hansen AB; Vibits H; Jepsen JV; Poulsen AL; Schwartz M; Horn T
Anticancer Res; 2004; 24(3a):1733-6. PubMed ID: 15274348
[TBL] [Abstract][Full Text] [Related]
18. Highly specific detection of prostate-specific antigen-positive cells in the blood of patients with prostate cancer or benign prostatic hyperplasia, using a real-time reverse-transcription-polymerase chain reaction method with improved sensitivity.
Barbero G; Destefanis P; Procida S; Mandili G; Ulliers D; Ceruti C; Fiori C; Maule MM; Fontana D; Giribaldi G; Turrini F
BJU Int; 2008 Dec; 102(11):1566-72. PubMed ID: 18549428
[TBL] [Abstract][Full Text] [Related]
19. Three distinct regions of allelic loss at 13q14, 13q21-22, and 13q33 in prostate cancer.
Hyytinen ER; Frierson HF; Boyd JC; Chung LW; Dong JT
Genes Chromosomes Cancer; 1999 Jun; 25(2):108-14. PubMed ID: 10337994
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity at 7q31.1 and 12p13-12 in advanced prostate cancer.
Kawana Y; Ichikawa T; Suzuki H; Ueda T; Komiya A; Ichikawa Y; Furuya Y; Akakura K; Igarashi T; Ito H
Prostate; 2002 Sep; 53(1):60-4. PubMed ID: 12210480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
